207 related articles for article (PubMed ID: 31636844)
21. Sex Differences in Lung Cancer.
May L; Shows K; Nana-Sinkam P; Li H; Landry JW
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370722
[TBL] [Abstract][Full Text] [Related]
22. [Innovations in biomarker development: a pathway towards individualized cancer therapy?].
Dumitru CA; Hoffmann TK; Lehnerdt G; Zeidler R; Lang S; Brandau S
Laryngorhinootologie; 2011 Mar; 90(3):168-77. PubMed ID: 21380962
[TBL] [Abstract][Full Text] [Related]
23. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
24. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
26. Updated overview of current biomarkers in head and neck carcinoma.
Dahiya K; Dhankhar R
World J Methodol; 2016 Mar; 6(1):77-86. PubMed ID: 27018324
[TBL] [Abstract][Full Text] [Related]
27. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
28. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
29. Pattern of head and neck cancer in Yemen.
Abdul-Hamid G; Saeed NM; Al-Kahiry W; Shukry S
Gulf J Oncolog; 2010 Jan; (7):21-4. PubMed ID: 20164005
[TBL] [Abstract][Full Text] [Related]
30. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract][Full Text] [Related]
31. Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
Vokes EE; Chu E
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):15-25. PubMed ID: 16736979
[TBL] [Abstract][Full Text] [Related]
32. Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.
Rose BR; Thompson CH; Tattersall MH; O'Brien CJ; Cossart YE
Aust N Z J Surg; 2000 Aug; 70(8):601-6. PubMed ID: 10945556
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment.
Inamura K; Ishikawa Y
J Clin Med; 2016 Mar; 5(3):. PubMed ID: 27005669
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients.
Fang WJ; Zheng Y; Wu LM; Ke QH; Shen H; Yuan Y; Zheng SS
Asian Pac J Cancer Prev; 2012; 13(5):1917-21. PubMed ID: 22901147
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
37. Sex disparities in cancer.
Zhu Y; Shao X; Wang X; Liu L; Liang H
Cancer Lett; 2019 Dec; 466():35-38. PubMed ID: 31541696
[TBL] [Abstract][Full Text] [Related]
38. Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.
Wang N; Zhou F; Xiong H; Du S; Ma J; Okai I; Wang J; Suo J; Hao L; Song Y; Hu J; Shao S
Anat Rec (Hoboken); 2012 May; 295(5):748-57. PubMed ID: 22419659
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
40. Differences in cancer survival by sex: a population-based study using cancer registry data.
Afshar N; English DR; Thursfield V; Mitchell PL; Te Marvelde L; Farrugia H; Giles GG; Milne RL
Cancer Causes Control; 2018 Nov; 29(11):1059-1069. PubMed ID: 30194549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
